Your browser doesn't support javascript.
loading
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy.
Azevedo-Silva, J; Tavares-Valente, D; Almeida, A; Queirós, O; Baltazar, F; Ko, Y H; Pedersen, P L; Preto, A; Casal, M.
Afiliação
  • Azevedo-Silva J; Department of Biology, Centre of Molecular and Environmental Biology (CBMA), University of Minho, Portugal, Campus de Gualtar, 4710-057, Braga, Portugal. joaosilva.bq@gmail.com.
  • Tavares-Valente D; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
  • Almeida A; Department of Sciences, IINFACTS - Institute of Research and Advanced Training in Health Sciences and Technologies, CESPU, CRL, University Institute of Health Sciences (IUCS), Gandra, Portugal.
  • Queirós O; Department of Biology, Centre of Molecular and Environmental Biology (CBMA), University of Minho, Portugal, Campus de Gualtar, 4710-057, Braga, Portugal.
  • Baltazar F; Department of Sciences, IINFACTS - Institute of Research and Advanced Training in Health Sciences and Technologies, CESPU, CRL, University Institute of Health Sciences (IUCS), Gandra, Portugal.
  • Ko YH; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.
  • Pedersen PL; KoDiscovery, LLC, University of Maryland BioPark, Suites 502 E & F, 801 West Baltimore St., Baltimore, MD, 21201, USA.
  • Preto A; Departments of Biological Chemistry and Oncology, Member at Large, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, 21205-2185, USA.
  • Casal M; Department of Biology, Centre of Molecular and Environmental Biology (CBMA), University of Minho, Portugal, Campus de Gualtar, 4710-057, Braga, Portugal.
Med Oncol ; 39(9): 121, 2022 Jun 18.
Article em En | MEDLINE | ID: mdl-35716210

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubulina (Proteína) / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Med Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubulina (Proteína) / Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Med Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Portugal